Download PDF
Endoskopie heute 2009; 22(1): 40-48
DOI: 10.1055/s-0028-1098833
Übersicht

© Georg Thieme Verlag Stuttgart ˙ New York

Bildgebende Tumordiagnostik

Diagnostic Imaging in OncologyF. Dammann1 , E. Schwaderer2
  • 1Radiologie, Klinik am Eichert, Göppingen, Akademisches Lehrkrankenhaus der Universität Ulm
  • 2Diagnostische und Interventionelle Radiologie, Universitätsklinik Tübingen
Further Information

Publication History

Publication Date:
13 March 2009 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die bildgebende Diagnostik liefert in Zusammenschau mit der klinischen Symptomatik und der histopathologischen Untersuchung heute die wesent­liche Basis zur Planung und Nachsorge ­aller onkologischen Behandlungsformen. Die Sono­grafie, die CT und die MRT bieten präzise morphologische Informationen als Basis für das Tumorstaging nach dem TNM-Schema. Nuklearmedizinische Verfahren wie z. B. die PET und spezielle MRT-Methoden erbringen zusätzliche funktionelle Informationen. Rasante Fortschritte der Modalitäten selbst und der computergestützten Bildverarbeitung führen durch eine stetige Verbesserung der diagnostischen Qualität zu veränderten Indikationsspektren. Neue diagnostische Verfahren fördern und ermöglichen die Entwicklung neuer therapeutischer Verfahren. Als Folge einer zunehmenden Integration bildgebender Diagnostik und therapeutischer Prozeduren ist in Zukunft auch eine Veränderung klinischer ­Abläufe und der interdisziplinären Zusammen­arbeit zu erwarten.

Abstract

Diagnostic imaging procedures provide crucial infor­mation for pretherapeutic planning and the follow-up of oncologic diseases. Ultrasound, CT and MRI provide detailed morphologic information and are actually used as the gold standard for tumor staging according to the TNM system. Nuclear medicine modalities and special MRI meth­ods allow for additional functional informa­tions. Fast-paced advancements of the imaging modalities and computerized image postprocessing tools provide important improvements of the diagnostic quality and value. Additionally, new imaging modalities have been developed which also support and enable the development of new therapeutic strategies. Progressive integration of diagnostic imaging and therapeutic procedures will presumably also have an impact on traditional clin­ical workflows and interdisciplinary cooperation.

Schlüsselwörter

onkologische Diagnostik - Untersuchungsmethoden - bildgestützte Behandlung

Key words

oncologic diagnosis - diagnostic methods - image guided therapy

Literatur

  • 1 Huppert P E, Lauchart W, Duda S H et al. Chemoembolisation des hepatozellularen Karzinoms: Welche Faktoren bestimmen Therapieansprechen und Überleben?.  RöFo Fortschr Röntgenstr. 2004;  176 375-385
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Hoffmann R T, Jakobs T F, Muacevic A et al. Interventionelle Onkologie bei Lungentumoren.  Radiologe. 2007;  47 1109-1116
    CrossrefPubMedGoogle Scholar
  • 3 Pereira P L. Actual role of radiofrequency ablation of liver metastases.  Eur Radiol. 2007;  17 2062-2070
    CrossrefPubMedGoogle Scholar
  • 4 König C W, Trübenbach J, Fritz J et al. Contrast enhanced MR-guided biopsy of hepatocellular carcinoma.  Abdom Imaging. 2004;  29 71-76
    PubMedGoogle Scholar
  • 5 Hashizume M. MRI-guided laparoscopic and robotic surgery for malignancies.  Int J Clin Oncol. 2007;  12 94-98
    CrossrefPubMedGoogle Scholar
  • 6 Kuhl C K, Schrading S, Bieling H B et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.  Lancet. 2007;  370 485-492
    CrossrefPubMedGoogle Scholar
  • 7 Schulz-Wendtland R, Hermann K P, Wacker T et al. Aktueller Stand und weitere Perspektiven der digitalen Mammographie.  Radiologe. 2008;  48 324-334
    CrossrefPubMedGoogle Scholar
  • 8 Fan Z H, Chen M H, Dai Y et al. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology.  AJR Am J Roentgenol. 2006;  186 1512-1519
    CrossrefPubMedGoogle Scholar
  • 9 Wu W, Chen M H, Yin S S et al. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy.  AJR Am J Roentgenol. 2006;  187 752-761
    CrossrefPubMedGoogle Scholar
  • 10 Horger M, Kanz L, Denecke B et al. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma.  Cancer. 2007;  109 1617-1626
    CrossrefPubMedGoogle Scholar
  • 11 McFarland E G, Levin B, Lieberman D A et al. Revised colorectal screening guidelines: joint effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology.  Radiology. 2008;  248 717-720
    CrossrefPubMedGoogle Scholar
  • 12 Bellomi M, Petralia G, Sonzogni A et al. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience.  Radiology. 2007;  244 486-493
    CrossrefPubMedGoogle Scholar
  • 13 Grenacher L, Thorn M, Knaebel H P et al. Bedeutung der 3-D-Bildgebung und computerbasierten Nachverarbeitung fur die Chirurgie der Leber und des Pankreas.  RöFo Fortschr Röntgenstr. 2005;  177 1219-1226
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Salah Z, Kastner M, Dammann F et al. Pre-operative planning of a complete mastoidectomy: Semi-automatic segmentation and evaluation.  JCARS. 2006;  1 213-222
    PubMedGoogle Scholar
  • 15 Dammann F, Hoffmann J, Horger M et al. Rational diagnosis of squamous cell carcinoma in the head and neck region: Comparative evaluation of CT, MRI, and 18FDG-PET.  AJR Am J Roentgenol. 2004;  184 1326-1331
    PubMedGoogle Scholar
  • 16 Wersebe A, Wiskirchen J, Decker U et al. Comparison of Gadolinium-BOPTA and Ferucarbotran-enhanced three-dimensional T1-weighted dynamic liver magnetic resonance imaging in the same patient.  Invest Radiol. 2006;  41 264-271
    CrossrefPubMedGoogle Scholar
  • 17 Yamada I, Okabe S, Enomoto M et al. Colorectal carcinoma: in vitro evaluation with high-spatial-resolution 3D-constructive interference in steady-state MR imaging.  Radiology. 2008;  246 444-453
    CrossrefPubMedGoogle Scholar
  • 18 Kwee T C, Takahara T, Ochiai R et al. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology.  Eur Radiol. 2008;  18 1937-1952
    CrossrefPubMedGoogle Scholar
  • 19 Schaefer J F, Schlemmer H P. Total-body MR-imaging in oncology.  Eur Radiol. 2006;  16 2000-2015
    CrossrefPubMedGoogle Scholar
  • 20 Giesel F L, Wüstenberg T, Bongers A et al. MR-basierte Methoden der funktionellen Bildgebung des zentralen Nervensystems.  RöFo Fortschr Röntgenstr. 2005;  177 714-730
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Chang J, Thakur S B, Huang W et al. Magnetic resonance spectroscopy imaging (MRSI) and brain functional magnetic resonance imaging (fMRI) for radiotherapy treatment planning of glioma.  Technol Cancer Res Treat. 2008;  7 349-362
    PubMedGoogle Scholar
  • 22 Hamstra D A, Rehemtulla A, Ross B D. Diffusion magnetic resonance ­imaging: a biomarker for treatment response in oncology.  J Clin Oncol. 2007;  25 4104-4109
    CrossrefPubMedGoogle Scholar
  • 23 Koh D M, Collins D J. Diffusion-weighted MRI in the body: applications and challenges in oncology.  AJR Am J Roentgenol. 2007;  188 1622-1635
    CrossrefPubMedGoogle Scholar
  • 24 Robbins E. Radiation risks from imaging studies in children with cancer.  Pediatr Blood Cancer. 2008;  51 453-457
    CrossrefPubMedGoogle Scholar
  • 25 Schenk J P, Graf N, Gunther P et al. Role of MRI in the management of ­patients with nephroblastoma.  Eur Radiol. 2008;  18 683-691
    CrossrefPubMedGoogle Scholar
  • 26 Hwang S, Panicek D M. Magnetic resonance imaging of bone marrow in oncology, Part 1.  Skeletal Radiol. 2007;  36 913-920
    CrossrefPubMedGoogle Scholar
  • 27 Frericks B B, Meyer B C, Martus P et al. MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT).  J Magn Reson Imaging. 2008;  27 538-545
    CrossrefPubMedGoogle Scholar
  • 28 Hwang S, Panicek D M. Magnetic resonance imaging of bone marrow in oncology, Part 2.  Skeletal Radiol. 2007;  36 1017-1027
    CrossrefPubMedGoogle Scholar
  • 29 Sharma N, Neumann D, Macklis R. The impact of functional imaging on radiation medicine.  Radiat Oncol. 2008;  3 25
    CrossrefPubMedGoogle Scholar
  • 30 Antoch G, Bockisch A. Combined PET / MRI: a new dimension in whole-body oncology imaging?.  Eur J Nucl Med Mol Imaging. 2008;  ,  [Epub ahead of print]
    PubMedGoogle Scholar
  • 31 Perry N et al. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th edition. European Communities 2006
    Google Scholar
  • 32 Frerich B, Forster M, Schiefke F et al. Sentinel lymph node biopsy in squamous cell carcinomas of the lips and the oral cavity – a single center experience.  J Surg Oncol. 2007;  95 97-105
    CrossrefPubMedGoogle Scholar
  • 33 Cademartiri F, Luccichenti G, Maffei E et al. Imaging for oncologic staging and follow-up: review of current methods and novel approaches.  Acta Biomed. 2008;  79 85-91
    PubMedGoogle Scholar
  • 34 Heussel C P, Meier S, Wittelsberger S et al. Quantitative CT-Verlaufs­kontrolle von Lebermalignomen nach RECIST und WHO im Vergleich zur Volumetrie.  RöFo Fortschr Röntgenstr. 2007;  179 958-964
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Mackie T R, Tome W. Advanced image-guided external beam radiotherapy.  Cancer Treat Res. 2008;  139 7-39
    PubMedGoogle Scholar
  • 36 Kwek J W, Iyer R B, Dunnington J et al. Spectrum of imaging findings in the abdomen after radiotherapy.  AJR Am J Roentgenol. 2006;  187 1204-1211
    CrossrefPubMedGoogle Scholar

Prof. Dr. F. Dammann

Radiologisches Zentralinstitut · Klinik am Eichert

Eichertstr. 3

73035 Göppingen

Phone: 0 71 61 / 64 20 15

Email: florian.dammann@kae.de

      >